BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11279653)

  • 1. Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells.
    Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CI; Dilber MS
    Am J Hematol; 2001 May; 67(1):20-6. PubMed ID: 11279653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes.
    Bansal R; Kumar M; Murray K; Pfeiffer SE
    Mol Cell Neurosci; 1996 Apr; 7(4):276-88. PubMed ID: 8793863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by integral membrane proteoglycan, syndecan.
    Sanderson RD; Sneed TB; Young LA; Sullivan GL; Lander AD
    J Immunol; 1992 Jun; 148(12):3902-11. PubMed ID: 1602136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells.
    Sneed TB; Stanley DJ; Young LA; Sanderson RD
    Cell Immunol; 1994 Feb; 153(2):456-67. PubMed ID: 8118875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndecan-1 in B lymphoid malignancies.
    Sanderson RD; Børset M
    Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proximal promoter-independent activation of the far-upstream FGF-inducible response element of syndecan-1 gene.
    Jaakkola P; Vihinen T; Jalkanen M
    Biochem Biophys Res Commun; 2000 Nov; 278(2):432-9. PubMed ID: 11097854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes.
    Yamashita Y; Oritani K; Miyoshi EK; Wall R; Bernfield M; Kincade PW
    J Immunol; 1999 May; 162(10):5940-8. PubMed ID: 10229831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart.
    Asundi VK; Keister BF; Stahl RC; Carey DJ
    Exp Cell Res; 1997 Jan; 230(1):145-53. PubMed ID: 9013716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.
    Numa F; Hirabayashi K; Tsunaga N; Kato H; O'Rourke K; Shao H; Stechmann-Lebakken C; Varani J; Rapraeger A; Dixit VM
    Cancer Res; 1995 Oct; 55(20):4676-80. PubMed ID: 7553648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
    Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
    Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis.
    Salminen-Mankonen H; Säämänen AM; Jalkanen M; Vuorio E; Pirilä L
    Scand J Rheumatol; 2005; 34(6):469-74. PubMed ID: 16393771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and localization of a developmental stage-specific promoter activity from the murine lambda 5 gene.
    Yang J; Glozak MA; Blomberg BB
    J Immunol; 1995 Sep; 155(5):2498-514. PubMed ID: 7650380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
    Licence S; Persson C; Mundt C; Mårtensson IL
    Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental expression of the syndecans: possible function and regulation.
    Bernfield M; Hinkes MT; Gallo RL
    Dev Suppl; 1993; ():205-12. PubMed ID: 8049475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
    Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
    Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
    Winkler S; Stahl RC; Carey DJ; Bansal R
    J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of syndecan in transformed mouse keratinocytes.
    Inki P; Gomez M; Quintanilla M; Cano A; Jalkanen M
    Lab Invest; 1992 Aug; 67(2):225-33. PubMed ID: 1501448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.